Pricing
US$ 29.21
glp-1 and gip/glp-1 receptor agonists The dual glucose-dependent insulinotropic polypeptide (GIP) glucagon-like peptide-1 (GLP-1) agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology The Landscape Of GLP-1 Receptor
Description
Retatrutide, a new weight-loss drug, helped people lose 30% of their body weight in a study, rivaling results seen with weight-loss surgery.
Very few include older adults at high risk
Marc Jean, DO, FACOG
Adult-onset type 1 diabetes mellitus differs from the early onset form in terms of residual endogenous insulin secretion, comorbidities and baseline cardiorenal risk
Learn how low-dose semaglutide and tirzepatide may support metabolism, menopause, inflammation, and autoimmune health.
